SCHEMBL17636668

SCHEMBL17636668

c1ccc(-c2c(-c3ccc4c(c3)c3ccccc3n4-c3cccc(-n4c5ccccc5c5ccccc54)c3)nnn2-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
DHODH Q02127 5/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
IDO1 P14902 2/20 0.37
TDO2 P48775 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 1/20 0.36
IL1R1 P14778 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
POLB P06746 1/20 0.35
CDC7 O00311 1/20 0.35
PLK4 O00444 1/20 0.35
AURKA O14965 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17636667 0.95 NPC1 (0.43) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL17636649 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL15762213 0.91 NPC1 (0.41) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL17636677 0.90 RAC2 (0.41) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL17636885 0.88 IDO1 (0.45) L3MBTL1KDM4EATMDHODHIDO1
SCHEMBL17636654 0.88 NPC1 (0.43) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL15762185 0.86 L3MBTL1 (0.45) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL15762182 0.86 L3MBTL1 (0.45) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL21532510 0.86 L3MBTL1 (0.36) L3MBTL1KDM4EATMDHODHNPC1
SCHEMBL17636671 0.86 GRM1 (0.45) L3MBTL1DHODHIDO1TDO2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 L3MBTL1 178/4885KDM4E 2877/4885ATM 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.